SCHEMBL5792347

SCHEMBL5792347

CCCCC(C#N)c1ccccc1N1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ LMNA P02545 2/20 0.39
▸ GAA P10253 1/20 0.38
▸ KDM4E B2RXH2 6/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ KEAP1 Q14145 1/20 0.37
▸ KCNQ2 O43526 3/20 0.37
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ CASP1 P29466 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ HBB P68871 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ USP2 O75604 2/20 0.36
▸ CCR1 P32246 2/20 0.35
▸ AR P10275 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5793534 0.82 GAA (0.41) ALDH1A1LMNAGAAKDM4ENPSR1
SCHEMBL5795936 0.80 LMNA (0.44) ALDH1A1LMNAGAAKDM4EKEAP1
SCHEMBL5792763 0.79 KEAP1 (0.44) ALDH1A1LMNAGAAKDM4EKEAP1
Hydrochloric Acid SCHEMBL17871814 0.78 KEAP1 (0.42) ALDH1A1LMNAGAAKDM4EKEAP1
SCHEMBL7900199 0.75 KEAP1 (0.42) ALDH1A1LMNAGAAKDM4EKEAP1
SCHEMBL6080834 0.75 KCNQ2 (0.49) ALDH1A1LMNAGAAKCNQ2MEN1
SCHEMBL5794047 0.74 LMNA (0.42) ALDH1A1LMNAGAAKDM4EKEAP1
SCHEMBL3729747 0.74 KCNQ2 (0.44) ALDH1A1LMNAGAAKEAP1KCNQ2
SCHEMBL4956719 0.74 KCNQ2 (0.44) ALDH1A1LMNAGAAKEAP1KCNQ2
SCHEMBL28309576 0.74 MEN1 (0.45) ALDH1A1LMNAGAAKEAP1KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses GENFIT (FR) 2006-04-13 — — US disclosed
WO-2006035157-A2 SUBSTITUTED N-(BENZYL)PHENYLACETAMIDE DERIVATIVE COMPOUNDS, PREPARATION METHOD THEREOF AND USES OF SAME AS PPAR LIGANDS IN THE TREATMENT OF LIPID AND/OR GLUCIDIC DISORDERS GENFIT (FR) 2006-04-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses AADAC, NAT1, PARN ALDH1A1 845/4885LMNA 1111/4885GAA 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback